我们非常重视您的个人隐私，当您访问我们的网站时，请同意使用的所有cookie。有关个人数据处理的更多信息可访问《隐私政策》

科学发表

论文

会议
  • February 12, 2026
    Intratracheal administration: Non-invasive approach for liver-targeted siRNA-LNP delivery

    10.26599/NR.2025.94908267

  • January 9, 2026
    RNA interference therapy targeting coagulation factor XI - a first-in-human trial of RBD4059

    10.1182/bloodadvances.2025018348

  • January 9, 2026
    Intratracheal administration: Non-invasive approach for liver-targeted siRNA-LNP delivery

    10.26599/NR.2025.94908267

  • July 8, 2025
    A Potent GalNAc-siRNA Drug, RBD1016, Leads to Sustained HBsAg Reduction and Seroconversion in Mouse Models of HBV infection

    doi: 10.1016/j.omtn.2025.102627

  • February 19, 2025
    Inhibition of Factor XI Using RBD4059: A Novel GalNAc-siRNA With Potent and Durable Antithrombotic Effects

    DOI: 10.1016/j.jacbts.2024.12.005

  • October 29, 2024
    GalNAc-Conjugated siRNA Targeting Complement C3 Inhibits Osteoclast Activation in Periodontitis

    DOI: 10.1111/odi.15170